Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Review of 2008: Innovation in ICDs continues amid calls for more strenuous testing

This article was originally published in Clinica

Executive Summary

2008 was a tempestuous year for developers of implantable cardioverter defibrillators (ICDs), small battery-powered devices that detect cardiac arrhythmia and correct it by delivering an electric shock. The year started with ICD companies in a difficult position; October 2007 had seen the disastrous recall, amid safety concerns, of Medtronic's Sprint Fidelis ICD lead. Whilst Medtronic has recovered from this to a large degree, the sector in general has been buffeted by negative trial results and calls for more stringent regulation of the devices and their peripherals.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT040915

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel